Randomized controlled trial of transfer factor in stage II malignant melanoma (Q70238275)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6336977%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

title

Randomized controlled trial of transfer factor in Stage II malignant melanoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6336977%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

Randomized controlled trial of transfer factor in stage II malignant melanoma (English)

1 reference

10.1002/1097-0142(19830115)51:2<269::AID-CNCR2820510217>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19830115)51:2%3C269::AID-CNCR2820510217%3E3.0.CO;2-6

randomized controlled trial

1 October 2023

main subject

1 reference

1 reference

10.1002/1097-0142(19830115)51:2<269::AID-CNCR2820510217>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19830115)51:2%3C269::AID-CNCR2820510217%3E3.0.CO;2-6

1 October 2023

author name string

R. M. Bukowski

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6336977

1 October 2023

S. Deodhar

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6336977

1 October 2023

J. S. Hewlett

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6336977

1 October 2023

R. Greenstreet

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6336977

1 October 2023

language of work or name

English

0 references

publication date

1 January 1983

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6336977%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

15 January 1983

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6336977

full work available at URL

1 October 2023

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1097-0142%2819830115%2951%3A2%3C269%3A%3AAID-CNCR2820510217%3E3.0.CO%3B2-6

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6336977

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(19830115)51:2%3C269::AID-CNCR2820510217%3E3.0.CO;2-6

1 October 2023

1 reference

10.1002/1097-0142(19830115)51:2<269::AID-CNCR2820510217>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19830115)51:2%3C269::AID-CNCR2820510217%3E3.0.CO;2-6

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(19830115)51:2%3C269::AID-CNCR2820510217%3E3.0.CO;2-6

1 October 2023

1 reference

10.1002/1097-0142(19830115)51:2<269::AID-CNCR2820510217>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19830115)51:2%3C269::AID-CNCR2820510217%3E3.0.CO;2-6

1 October 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6336977%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

volume

51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6336977%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6336977%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

page(s)

269-272

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6336977%20AND%20SRC:MED&resulttype=core&format=json

Adjuvant Immunotherapy with BCG in Treatment of Regional-Lymph-Node Metastases from Malignant Melanoma

9 October 2019

cites work

1

1 reference

10.1002/1097-0142(19830115)51:2<269::AID-CNCR2820510217>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19830115)51:2%3C269::AID-CNCR2820510217%3E3.0.CO;2-6

Thymosin fraction V and intensive combination chemotherapy. Prolonging the survival of patients with small-cell lung cancer

1 October 2023

4

1 reference

10.1002/1097-0142(19830115)51:2<269::AID-CNCR2820510217>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19830115)51:2%3C269::AID-CNCR2820510217%3E3.0.CO;2-6

Journal of Clinical Investigation

1 October 2023

6

33

951

Lawrence

1954

1 reference

10.1002/1097-0142(19830115)51:2<269::AID-CNCR2820510217>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19830115)51:2%3C269::AID-CNCR2820510217%3E3.0.CO;2-6

Does Transfer Factor Act Specifically or as an Immunologic Adjuvant?

1 October 2023

7

1 reference

10.1002/1097-0142(19830115)51:2<269::AID-CNCR2820510217>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19830115)51:2%3C269::AID-CNCR2820510217%3E3.0.CO;2-6

Effect of transfer factor therapy on mixed lymphocyte culture reactivity

1 October 2023

8

1 reference

10.1002/1097-0142(19830115)51:2<269::AID-CNCR2820510217>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19830115)51:2%3C269::AID-CNCR2820510217%3E3.0.CO;2-6

Effects of dialyzable transfer factor in patients with breast cancer

1 October 2023

10

1 reference

10.1002/1097-0142(19830115)51:2<269::AID-CNCR2820510217>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19830115)51:2%3C269::AID-CNCR2820510217%3E3.0.CO;2-6

A review of transfer factor immunotherapy in cancer

1 October 2023

11

1 reference

10.1002/1097-0142(19830115)51:2<269::AID-CNCR2820510217>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19830115)51:2%3C269::AID-CNCR2820510217%3E3.0.CO;2-6

Proceedings: Immunotherapy of malignant disease: the use of viable sensitized lymphocytes or transfer factor prepared from sensitized lymphocytes

1 October 2023

12

1 reference

10.1002/1097-0142(19830115)51:2<269::AID-CNCR2820510217>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19830115)51:2%3C269::AID-CNCR2820510217%3E3.0.CO;2-6

Demonstration of cell-mediated immunity to human neoplasms of various histological types

1 October 2023

16

1 reference

10.1002/1097-0142(19830115)51:2<269::AID-CNCR2820510217>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19830115)51:2%3C269::AID-CNCR2820510217%3E3.0.CO;2-6

Adjuvant immunotherapy of high risk stage I melanoma with transfer factor

1 October 2023

18

1 reference

10.1002/1097-0142(19830115)51:2<269::AID-CNCR2820510217>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19830115)51:2%3C269::AID-CNCR2820510217%3E3.0.CO;2-6

1 October 2023

Identifiers

10.1002/1097-0142(19830115)51:2<269::AID-CNCR2820510217>3.0.CO;2-6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6336977%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

1 reference